Clinical Trial Update: Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated whether implantable cardioverter-defibrillator therapy reduces sudden death after a myocardial infarction and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Sudden Cardiac Death

Drugs mentioned

• Implantable cardioverter-defibrillator (ICD) (implantable cardioverter-defibrillator)

Snippet

Sponsor: University of Calgary | Conditions: Myocardial Infarction, Sudden Death | Phase 3 | Status: COMPLETED